Lv5
920 积分 2024-03-18 加入
Artificial intelligence for natural product drug discovery
1个月前
已完结
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
3个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5个月前
已完结
Engineered exosomes: a transformative therapeutic modality
9个月前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
9个月前
已完结
Fcγ receptors and immunomodulatory antibodies in cancer
10个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
10个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
10个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
10个月前
已完结
Interleukin-2–based therapies in cancer
11个月前
已完结
皖公网安备34019202002308
